US STOCKS: Late Equities Roundup: Extending Lows Into Expiration, Other Factors

Feb-21 19:28
  • Stocks continued to extend lows late Friday with SPX Eminis and Nasdaq at last week Thursday levels while the DJIA retreats to 4 week lows. Currently, the DJIA trades down 773.52 points (-1.75%) at 43579.27, S&P E-Minis down 100.25 points (-1.63%) at 6062.75, Nasdaq down 394.9 points (-2%) at 19665.11.
  • Several factors were in play Friday, stocks reversed modest early gains, extended session lows after this morning's weaker than expected economic data (S&P flash Services PMI below 50, Existing home sales were softer than expected while the final University of Michigan consumer survey for February showed a worrying rise in long-term inflation expectations.
  • Trading desks also cited today's call weighted option expiration that has historically leaned toward bearish price action in the week after. President Trump reiterating a 25% tariff on cars starting April 2 didn't help either. But wires recirculating a South China Morning Post article regarding new Covid strain with "pandemic potential" triggered renewed risk-off selling vs. buying in Treasuries (TYH5 hit 109-24 high +18.5; yield falling to 4.4042% low.)
  • Consumer Discretionary and Industrials continued to underperform in late trade, autos and travel related stocks weighing on the Consumer sector: Norwegian Cruise Line -6.37%, Airbnb Inc -5.65%, Carnival Corp-5.62% and Tesla -4.47%. GE Vernova -8.17%, Builders FirstSource -5.74%, Howmet Aerospace -5.28% and United Rentals Inc -5.21% weighed on the Industrial sector.
  • On the positive side, Consumer Staples and Utilities outperformed in the second half, food & beverage shares leading gainers: Hershey Co +4.58%, Conagra Brands +4.31%, Campbell's Company +3.76%, Mondelez International Inc +3.67%. American Water Works +3.11%, Consolidated Edison +3.07%, Dominion Energy +1.92% and Duke Energy +1.86% led gainers in the Utility sector.
  • Of note, pharmaceutical stocks rallied on the re-aired Covid headlines, Moderna climbing to 35.90 high from 33.18 low. On the flipside, United Health Care shares were -6.75% as DOJ investigated fraud charges.

Historical bullets

FED: MNI Hawk-Dove Spectrum Shifts, Easing Bias Remains Overall (2/2)

Jan-22 19:23

We’ve updated our Hawk-Dove Spectrum for 2025, with the rotation of regional president voters bringing in Chicago Fed’s Goolsbee (dove), KC’s Schmid (hawk), St Louis’s Musalem (hawk), and Boston’s Collins (neutral/dove) for 2024. (Out are the neutral/hawkish Bostic and Barkin, hawk Hammack, and neutral/dovish Daly).

  • All participants remain on the dovish side of the Hawk-Dove line in absolute terms, reflecting the Committee’s overall easing bias.
  • However most of the Dots have been moved in a more hawkish direction in the last 6 weeks, in light of the more limited cuts seen in the December Dot Plot and the growing sentiment that the FOMC can remain patient in deciding when to cut next.
  • We now regard Hammack as the FOMC’s biggest hawk, though only marginally over her colleagues Bowman, Schmid and Musalem.
  • Conversely, Gov Waller has ensconced himself as one of the pre-eminent doves on the Committee, seeing potential for 3-4 cuts this year, and possibly restarting the easing cycle earlier than market pricing implies (though he spoke after the December CPI data).
image

CANADA: Analyst USDCAD Scenarios Under Trump Tariffs

Jan-22 19:20
  • CIBC: Full 25% tariffs look unlikely. They see USDCAD peaking at 1.461 and 1.468 with 10% tariffs or 1.478 and 1.496 with 20% tariffs under carve-outs for both energy and auto sectors or just for energy sectors.
  • “The market implied probability of spot moving above 1.4610 by Q2 is just over 20%; above 1.4960 is just over 10%. This implies that while high-stake tariffs are not expected to be the base case, the market has assigned a larger-than-zero chance that they can happen.”
  • DB: In a full 25% tariff scenario with no fiscal response, USDCAD should move to “at least 1.53, with a very real possibility that it tests the 2002 all-time highs of 1.61. By extension, USD/CAD is one of the most under-priced FX crosses for an FX trade war.”
  • ING: “USD/CAD has been flat since the start of the year, and still embedding a 3% risk premium associated with the risk of Trump’s tariffs – according to our short-term fair value model. Even if unilateral 25% tariffs on Canada don’t materialise, smaller universal tariffs would still asymmetrically damage the economy of the main US trade partners. […] To rebound at this stage, CAD requires more reports suggesting a lighter-touch approach by Trump on trade. Barring that, we expect the risk premium to linger and some support around 1.430 in USD/CAD.”
  • JPM: “1.55-1.58 is consistent with full pass-through from our USD tariffs beta [with permanent tariffs and no carve-outs]. […] But those elevated USD/CAD targets could prove temporary” if negative spillover back to the US impacts the USD leg, “providing some eventual offset to higher USD/CAD estimates.”
  • “USD/CAD sub-1.40 is possible if no tariffs are ultimately introduced, risk premium is depriced, CAD shorts are trimmed, and less trade uncertainty allows other improving domestic factors to boost CAD.”
  • MUFG: “If there’s no sign of negotiations or progress in negotiations and Trump keeps repeating his plans, we will see USD/CAD and USD/MXN jump notably higher. Our USD/CAD forecasts for Q1 and Q2 (1.4500 & 1.4400) did not incorporate a broad-based 25% tariff. The 2020 high (1.4668) and the 2016 high (1.4690) would likely be taken out quickly and a move into a 1.5000-1.6000 range (last seen in 2003) would come into play.”

FED: Key Inter-Meeting Fed Speak – Jan 2025

Jan-22 19:01

Ahead of next week's Fed decision, we've published our summary of FOMC participant communications since the December FOMC meeting, including analysis of the latest Beige Book and MNI's Hawk-Dove Matrix. 

PDF Analysis:

FedSpeakJan2025.pdf